Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Operating Expenses: 2011-2016

Historic Other Operating Expenses for Tenax Therapeutics (TENX) over the last 5 years, with Dec 2016 value amounting to $33.3 million.

  • Tenax Therapeutics' Other Operating Expenses was N/A to $33.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $34.9 million, marking a year-over-year change of. This contributed to the annual value of $33.3 million for FY2016, which is N/A change from last year.
  • As of FY2016, Tenax Therapeutics' Other Operating Expenses stood at $33.3 million, which was up 3,114.44% from $1.0 million recorded in FY2015.
  • Tenax Therapeutics' Other Operating Expenses' 5-year high stood at $33.3 million during FY2016, with a 5-year trough of $27,279 in FY2013.
  • Its 2-year average for Other Operating Expenses is $17.1 million, with a median of $17.1 million in 2015.
  • Data for Tenax Therapeutics' Other Operating Expenses shows a maximum YoY plummeted of 90.22% (in 2012) over the last 5 years.
  • Over the past 4 years, Tenax Therapeutics' Other Operating Expenses (Yearly) stood at $29,534 in 2012, then dropped by 7.64% to $27,279 in 2013, then reached $1.0 million in 2015, then reached $33.3 million in 2016.